Among patients with lymphoma undergoing a certain type of chemotherapy, receiving the antiviral drug entecavir resulted in a lower incidence of hepatitis B virus (HBV)-related hepatitis and HBV reactivation, compared with the antiviral drug lamivudine, according to a study.
from Today's Healthcare News -- ScienceDaily http://ift.tt/1AlW9Oi
from Today's Healthcare News -- ScienceDaily http://ift.tt/1AlW9Oi
No comments:
Post a Comment